YTHDF1 in Tumor Cell Metabolism: An Updated Review

Haichuan Rong1, Danyang Wang1, Yiran Wang1

  • 1Key Laboratory of Cell Biology, Department of Cell Biology, Ministry of Public Health and Key Laboratory of Medical Cell Biology, Ministry of Education, China Medical University, Shenyang 110122, China.

PubMed

Insights

YTHDF1, an m6A reader, is crucial for tumor progression, affecting translation, proliferation, metabolism, and immune evasion. This review highlights its signaling pathways and metabolic reprogramming roles, suggesting YTHDF1 as a promising cancer therapeutic target.

Area of Science:

  • Oncology
  • Molecular Biology
  • Epigenetics

Background:

  • N6-methyladenosine (m6A) modifications are crucial epigenetic regulators in cancer.
  • The YTHDF protein family, particularly YTHDF1, acts as a key reader of m6A modifications.
  • YTHDF1 is increasingly recognized for its multifaceted roles in tumor biology.

Purpose of the Study:

  • To review the latest signaling pathway mechanisms of YTHDF1 in various tumor cells.
  • To emphasize YTHDF1's role in tumor cell metabolic reprogramming.
  • To analyze YTHDF1's pathological and physiological processes and explore therapeutic strategies.

Main Methods:

  • Literature review of recent studies on YTHDF1.
  • Analysis of signaling pathways regulated by YTHDF1.
  • Investigation of YTHDF1's impact on tumor cell metabolism and progression.

Main Results:

  • YTHDF1 significantly influences protein translation, tumor proliferation, and immune evasion.
  • YTHDF1 plays a critical role in the metabolic reprogramming of tumor cells.
  • YTHDF1 interacts with various upstream and downstream factors to regulate tumor progression.

Conclusions:

  • YTHDF1 is a pivotal regulator of tumor progression through diverse signaling pathways and metabolic reprogramming.
  • YTHDF1 exhibits unique characteristics in influencing tumor cell metabolism.
  • YTHDF1 represents a promising therapeutic target and a novel biomarker for cancer treatment.

Related Concept Videos

Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.8K
Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
13.4K
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.6K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.8K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
3.6K